Associate Professor Hongchao Pan
Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine. Since joining CTSU in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies.
His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking. Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: email@example.com None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
(2022), The Lancet, 399, 1941 - 1953
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium None. et al, (2020), N Engl J Med
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
PAN H. and Peto R., (2020), MedRxiv
Smoking and risk of Parkinson's disease: 65 year follow-up of the British Doctors study
CLARKE R. et al, (2020), Neurology